{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"1.45","value":"2.6"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"15"}],"units":"Participants"}],"dispersionType":"Standard Deviation","groups":[{"description":"Twice-weekly dosing with 2-hour IV infusions on days 1,4,8, and 11 of 3-week cycles","id":"OG000","title":"MRZ 0.5 mg/m^2"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"Through study completion, an average of 6.09 weeks.","title":"Number of Cycles of Marizomib (MRZ)","type":"SECONDARY","unitOfMeasure":"cycles"}